The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-κB signal transduction pathway
- 12 December 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (57) , 8759-8768
- https://doi.org/10.1038/sj.onc.1206033
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 46 references indexed in Scilit:
- Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancerCancer Letters, 2002
- Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphomaGenes, Chromosomes and Cancer, 2002
- IκBβ, but Not IκBα, Functions as a Classical Cytoplasmic Inhibitor of NF-κB Dimers by Masking Both NF-κB Nuclear Localization Sequences in Resting CellsJournal of Biological Chemistry, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- How NF-κB is activated: the role of the IκB kinase (IKK) complexOncogene, 1999
- The Rel/NF-κB signal transduction pathway: introductionOncogene, 1999
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- The protein truncation test: A reviewHuman Mutation, 1999
- Chromosomal localization of the genes encoding the p50/p105 subunits of NF-κB (NFKB2) and the IκB/MAD-3 (NFKBI) inhibitor of NF-κB to 4q24 and 14q13, respectivelyGenomics, 1992
- Characterization of a new human lymphoma cell line (RC-K8) with t(11;14) chromosome abnormalityCancer, 1986